<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00835731</url>
  </required_header>
  <id_info>
    <org_study_id>SFP2-3</org_study_id>
    <nct_id>NCT00835731</nct_id>
  </id_info>
  <brief_title>Misoprostol Versus Dilapan-S for Cervical Preparation</brief_title>
  <official_title>Cervical Preparation Before Same-day Second Trimester Abortion With Buccal Misoprostol Versus Dilapan-S: A Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Planned Parenthood League of Massachusetts</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Society of Family Planning</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Planned Parenthood League of Massachusetts</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the dilatory effect of 400 mcg of buccally
      administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation
      and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cervical Dilation in Women Following Exposure to Either Ripening Agent</measure>
    <time_frame>3-4 hours after placement of ripening agent</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ease of Further Mechanical Dilation in Women Following Exposure to Either Ripening Agent, as Per MD Report</measure>
    <time_frame>3-4 hours after placement of ripening agent</time_frame>
    <description>Scale:
None needed (score of 0) Very easy (score 1) Somewhat easy (score of 2) Moderate (score of 3) Somewhat difficult (score of 4) Very difficult (score of 5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Time for Dilation and Evacuation</measure>
    <time_frame>3-4 hours after placement of ripening agent</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients for Whom Physician Was Able to Complete Dilation and Evacuation Procedure on First Attempt</measure>
    <time_frame>3-4 hours after placement of ripening agent</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Pain During Ripening</measure>
    <time_frame>3-4 hours after placement of ripening agent</time_frame>
    <description>Measure assesses patient pain during cervical preparation. Pain was assessed after cervical ripening was complete, immediately before D&amp;E procedure. Subjects were asked to rate pain on a 6 point Likert scale:
0 = no pain 1-2 = mild pain 3 = moderate pain 4-5 = severe pain
Higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Pain During Dilation and Evacuation</measure>
    <time_frame>3-4 hours after placement of ripening agent</time_frame>
    <description>Measure assesses subject pain during dilation and evacuation. Pain was assessed immediately after the D&amp;E procedure. Subjects were asked to rate pain on a 6 point Likert scale:
0 = no pain 1-2 = mild pain 3 = moderate pain 4-5 = severe pain
Higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Women's Satisfaction With Cervical Ripening Method</measure>
    <time_frame>5 hours after placement of ripening agent</time_frame>
    <description>Scale:
1 = very dissatisfied, 2 = dissatisfied, 3 = neutral, 4 = satisfied, 5 = very satisfied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Cervical Ripening</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400mcg buccal misoprostol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dilapan-S, control: vitamin B-12 administered sublingually</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>misoprostol</intervention_name>
    <description>400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Cytotec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilapan-S, vitamin B-12</intervention_name>
    <description>One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E. Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  medically eligible for dilation and evacuation at Planned Parenthood League of
             Massachusetts

          -  gestational age 12 weeks 0 days to 15 weeks 0 days as evaluated by ultrasound

          -  proficient in English or Spanish

          -  agreeing to study procedures, including randomization and surveys regarding
             demographics, medical and gynecological history, and assessments of pain and
             satisfaction

        Exclusion Criteria:

          -  less than 18 years old

          -  cervical or uterine anomaly that the research physician deems may affect the
             difficulty of dilation or the abortion procedure

          -  inflammatory bowel disease

          -  contraindication to misoprostol use

          -  known intolerance or allergy to misoprostol or Dilapan-S

          -  inability to give informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prinicpal Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Planned Parenthood League of Massachusetts</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Planned Parenthood League of Massachusetts</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2009</study_first_submitted>
  <study_first_submitted_qc>February 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2009</study_first_posted>
  <results_first_submitted>June 13, 2013</results_first_submitted>
  <results_first_submitted_qc>November 20, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 7, 2014</results_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>induced abortion</keyword>
  <keyword>misoprostol</keyword>
  <keyword>cervical ripening</keyword>
  <keyword>second trimester abortion</keyword>
  <keyword>Dilapan-S</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Dates of recruitment period: January 2009 - December 2011 We recruited English- or Spanish-speaking women who were in good health, at least 18 years old, and between 12 weeks 0 days and 15 weeks 0 days gestation by ultrasound examination, seeking outpatient pregnancy termination at Planned Parenthood League of MA.</recruitment_details>
      <pre_assignment_details>Patients were recruited for study participation on the day of their pregnancy termination procedure. All study procedures occurred on the day that the patient was enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Misoprostol</title>
          <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
        </group>
        <group group_id="P2">
          <title>Synthetic Osmotic Dilator</title>
          <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Misoprostol</title>
          <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
        </group>
        <group group_id="B2">
          <title>Synthetic Osmotic Dilator</title>
          <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="64"/>
            <count group_id="B2" value="61"/>
            <count group_id="B3" value="125"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="125"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.1" spread="5.5"/>
                    <measurement group_id="B2" value="24.0" spread="5.0"/>
                    <measurement group_id="B3" value="24.0" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="125"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cervical Dilation in Women Following Exposure to Either Ripening Agent</title>
        <time_frame>3-4 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Cervical Dilation in Women Following Exposure to Either Ripening Agent</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.1" spread="6.0"/>
                    <measurement group_id="O2" value="33.9" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ease of Further Mechanical Dilation in Women Following Exposure to Either Ripening Agent, as Per MD Report</title>
        <description>Scale:
None needed (score of 0) Very easy (score 1) Somewhat easy (score of 2) Moderate (score of 3) Somewhat difficult (score of 4) Very difficult (score of 5)</description>
        <time_frame>3-4 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Further Mechanical Dilation in Women Following Exposure to Either Ripening Agent, as Per MD Report</title>
          <description>Scale:
None needed (score of 0) Very easy (score 1) Somewhat easy (score of 2) Moderate (score of 3) Somewhat difficult (score of 4) Very difficult (score of 5)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>None needed (score of 0)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very-somewhat easy (score of 1-2)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate (score of 3)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat-very difficult (score of 4-5)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure Time for Dilation and Evacuation</title>
        <time_frame>3-4 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Time for Dilation and Evacuation</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" lower_limit="2.0" upper_limit="3.8"/>
                    <measurement group_id="O2" value="3.0" lower_limit="2.2" upper_limit="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients for Whom Physician Was Able to Complete Dilation and Evacuation Procedure on First Attempt</title>
        <time_frame>3-4 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients for Whom Physician Was Able to Complete Dilation and Evacuation Procedure on First Attempt</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Pain During Ripening</title>
        <description>Measure assesses patient pain during cervical preparation. Pain was assessed after cervical ripening was complete, immediately before D&amp;E procedure. Subjects were asked to rate pain on a 6 point Likert scale:
0 = no pain 1-2 = mild pain 3 = moderate pain 4-5 = severe pain
Higher values represent a worse outcome.</description>
        <time_frame>3-4 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Pain During Ripening</title>
          <description>Measure assesses patient pain during cervical preparation. Pain was assessed after cervical ripening was complete, immediately before D&amp;E procedure. Subjects were asked to rate pain on a 6 point Likert scale:
0 = no pain 1-2 = mild pain 3 = moderate pain 4-5 = severe pain
Higher values represent a worse outcome.</description>
          <units>Scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Pain During Dilation and Evacuation</title>
        <description>Measure assesses subject pain during dilation and evacuation. Pain was assessed immediately after the D&amp;E procedure. Subjects were asked to rate pain on a 6 point Likert scale:
0 = no pain 1-2 = mild pain 3 = moderate pain 4-5 = severe pain
Higher values represent a worse outcome.</description>
        <time_frame>3-4 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Pain During Dilation and Evacuation</title>
          <description>Measure assesses subject pain during dilation and evacuation. Pain was assessed immediately after the D&amp;E procedure. Subjects were asked to rate pain on a 6 point Likert scale:
0 = no pain 1-2 = mild pain 3 = moderate pain 4-5 = severe pain
Higher values represent a worse outcome.</description>
          <units>Scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Women's Satisfaction With Cervical Ripening Method</title>
        <description>Scale:
1 = very dissatisfied, 2 = dissatisfied, 3 = neutral, 4 = satisfied, 5 = very satisfied</description>
        <time_frame>5 hours after placement of ripening agent</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Misoprostol</title>
            <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
          </group>
          <group group_id="O2">
            <title>Synthetic Osmotic Dilator</title>
            <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
          </group>
        </group_list>
        <measure>
          <title>Women's Satisfaction With Cervical Ripening Method</title>
          <description>Scale:
1 = very dissatisfied, 2 = dissatisfied, 3 = neutral, 4 = satisfied, 5 = very satisfied</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O2" value="4" lower_limit="4" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Misoprostol</title>
          <description>400mcg buccal misoprostol
misoprostol : 400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D&amp;E</description>
        </group>
        <group group_id="E2">
          <title>Synthetic Osmotic Dilator</title>
          <description>Dilapan-S, control: vitamin B-12 administered sublingually
Dilapan-S, vitamin B-12 : One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D&amp;E.
Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D&amp;E</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Same-day re-evacuation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <description>estimated blood loss of 300 cc</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cervical laceration</sub_title>
                <description>minor, treated with cervical pressure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Principal Investigator</name_or_title>
      <organization>Planned Parenthood League of Massachusetts</organization>
      <phone>6176161600</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

